Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Child Adolesc Psychiatr Clin N Am ; 32(2): 421-450, 2023 04.
Artigo em Inglês | MEDLINE | ID: covidwho-20245186

RESUMO

Eating disorders (EDs) are a non-heterogeneous group of illnesses with significant physical and mental comorbidity and mortality associated with maladaptive coping. With the exception of lisdexamfetamine (Vyvanse) for binge eating disorder, no medications have been effective for the core symptoms of ED. ED requires a multimodal approach. Complementary and integrative medicine (CIM) can be helpful as an adjunct. The most promising CIM interventions are traditional yoga, virtual reality, eye movement desensitization and reprocessing, Music Therapy, and biofeedback/neurofeedback.


Assuntos
Terapia por Acupuntura , Anorexia Nervosa , Arteterapia , Transtorno da Compulsão Alimentar , Bulimia Nervosa , Transtornos da Alimentação e da Ingestão de Alimentos , Medicina Integrativa , Neurorretroalimentação , Realidade Virtual , Yoga , Humanos , Adolescente , Bulimia Nervosa/terapia , Espiritualidade , Transtorno da Compulsão Alimentar/diagnóstico , Dimesilato de Lisdexanfetamina , Fototerapia , Anorexia Nervosa/diagnóstico
4.
J Paediatr Child Health ; 58(3): 491-496, 2022 03.
Artigo em Inglês | MEDLINE | ID: covidwho-1438041

RESUMO

AIM: The coronavirus (COVID-19) pandemic has led to increased concerns about adolescent mental health. This study aimed to determine the effect of the pandemic on adolescent eating disorders (EDs) by measuring changes in the number and severity of presentations to an Australian paediatric ED service that utilises a standardised approach to triage and assessment. METHODS: A 4-year retrospective chart review (2017-2020) of all patients (n = 457) presenting to the Royal Children's Hospital Eating Disorder Service, Melbourne, was undertaken. The incidence of each diagnosis and measures of condition severity were extracted from the database and patient medical records. Clinical comments relating to the impact of COVID-19, on both ED behaviours and treatment, were also noted. RESULTS: Annual presentations increased from a mean of 98.7 per annum from 2017 to 2019 to 161 in 2020 (63% increase). COVID-19 restrictions were reported to be a trigger for ED behaviours in 40.4% of adolescents diagnosed with anorexia nervosa in 2020. There was no significant difference in severity across years despite increased cases. CONCLUSIONS: The dramatic increase in presentations has implications for primary health and paediatric care as well as specialist ED services. Increased support is needed for EDs during this time.


Assuntos
Anorexia Nervosa , COVID-19 , Adolescente , Anorexia Nervosa/diagnóstico , Anorexia Nervosa/epidemiologia , Anorexia Nervosa/psicologia , Austrália/epidemiologia , COVID-19/epidemiologia , Criança , Hospitais Pediátricos , Humanos , Pandemias , Estudos Retrospectivos , SARS-CoV-2
5.
Eur Eat Disord Rev ; 29(4): 670-679, 2021 07.
Artigo em Inglês | MEDLINE | ID: covidwho-1216170

RESUMO

OBJECTIVES: To investigate the validity and reliability of two variants of the Sit Up Squat Stand Test (SUSS) and Hand Grip Strength (HGS) in predicting BMI and BMI risk level in hospitalised patients with Anorexia Nervosa (AN). METHODS: 25 inpatients with AN were tested roughly weekly for up to 16 weeks. Muscle power was assessed by two independent researchers. RESULTS: Intra-class coefficients (ICCs) indicated high Inter-Rater Reliability (IRR) for the HGS (10 participants). Cohen's Kappa showed moderate IRR for the SUSS test (25 participants). Stepwise multiple regression showed that the SUSS tests plus HGS predicted BMI and BMI risk level explaining about two-third of the variance. Each test individually had lower predictive value. There was a little difference between the two versions of the SUSS tested. CONCLUSIONS: HGS and SUSS are valid and reliable measurements of muscle power in AN. Together, the SUSS tests and the HGS represent a useful and effective measure of muscle power and hence one aspect of physical risk in Anorexia Nervosa. In the light of Covid restrictions, the SUSS test is one way that physical state can be monitored on video link in a way that is hard to falsify.


Assuntos
Anorexia Nervosa , COVID-19 , Anorexia Nervosa/diagnóstico , Força da Mão/fisiologia , Humanos , Músculos , Reprodutibilidade dos Testes , Medição de Risco
6.
Neurosurg Focus ; 49(6): E11, 2020 12.
Artigo em Inglês | MEDLINE | ID: covidwho-953947

RESUMO

OBJECTIVE: The ongoing coronavirus disease 2019 (COVID-19) pandemic has considerably affected the delivery of postoperative care to patients who have undergone deep brain stimulation (DBS) surgery. DBS teleprogramming technology was developed and deployed in China before the COVID-19 outbreak. In this report, the authors share their experiences with telemedical DBS treatment of patients with psychiatric disorders during the COVID-19 outbreak. METHODS: Four patients (2 with obsessive-compulsive disorder, 1 with major depressive disorder, and 1 with anorexia nervosa) underwent DBS surgery at Ruijin Hospital and received continuous postoperative DBS telemedicine case management from January 2020 to July 2020. DBS teleprogramming, individualized psychological support, and medical consultations were provided via the authors' DBS telemedicine platform, which also incorporated a synchronous real-time video communication system. RESULTS: Forty-five DBS telemedicine sessions were conducted; there was no unexpected loss of network connection during the sessions. Of these, 28 sessions involved DBS teleprogramming. Adjustments were made to the stimulation voltage, frequency, pulse width, and contact site in 21, 12, 9, and 9 sessions, respectively. Psychological support and troubleshooting were provided during the remaining telemedicine sessions. Modest to substantial clinical improvements after DBS surgery were observed in some but not all patients, whereas stimulation-related side effects were reported by 2 patients and included reversible sleep and mood problems, headache, and a sensation of heat. CONCLUSIONS: DBS telemedicine seems to offer a feasible, safe, and efficient strategy for maintaining the delivery of medical care to psychiatric patients during the COVID-19 outbreak. The authors propose that implementation of a comprehensive DBS telemedicine system, which combines DBS teleprogramming with psychological counseling, medical consultations, and medication prescriptions and delivery, could be an efficient and effective approach to manage the mental health and quality of life of patients with psychiatric disorders during future local or global public health crises.


Assuntos
Anorexia Nervosa/cirurgia , COVID-19/epidemiologia , Estimulação Encefálica Profunda/métodos , Transtorno Depressivo Maior/cirurgia , Transtorno Obsessivo-Compulsivo/cirurgia , Telemedicina/métodos , Anorexia Nervosa/diagnóstico , Anorexia Nervosa/psicologia , Estimulação Encefálica Profunda/normas , Transtorno Depressivo Maior/diagnóstico , Transtorno Depressivo Maior/psicologia , Seguimentos , Humanos , Transtornos Mentais , Transtorno Obsessivo-Compulsivo/diagnóstico , Transtorno Obsessivo-Compulsivo/psicologia , Estudos Retrospectivos , Telemedicina/normas , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA